News

Patients with sarcoidosis may develop a condition known as autoimmune hemolytic anemia, in which the red blood cells are prematurely destroyed by the immune system. Although this is not well documented, researchers at Warwick Hospital in England have reported the case of a patient who exhibited both illnesses. Their study,…

There is a difference in the composition of microorganisms in the respiratory tract of people with sarcoidosis and that of healthy individuals according to a study conducted by Polish scientists. The authors of the study suggest that this may be a factor contributing to an increased colonization of the airways by opportunistic pathogenic bacteria.

Poor cardiac outcomes in patients with cardiac sarcoidosis may be predicted through the presence of cardiac fibrosis assessed by heart magnetic resonance imaging (MRI), according to a recent Japanese study. The study, “Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with…

The results of a clinical study conducted over 20 years in a group of patients seen and treated at three large teaching hospitals in London shows that patients with sarcoidosis who experience an inflammatory optic neuropathy, or damage to the optic nerve due to inflammation, respond to treatment with corticosteroids.

Researchers at the National Research Institute of TB & Lung Diseases, in Poland, have developed a novel tool that helps identify patients with cardiac sarcoidosis via easily accessible and cost-effective tests. The study “Prevalence of cardiac sarcoidosis in white population: a case–control study: Proposal for a novel risk…

It is important to perform a lung biopsy when a change in chest X-ray is seen during pulmonary sarcoidosis monitoring, according to research conducted by Japanese scientists. This way, the rare possibility of complication with multicentric Castleman’s disease (MCD) can be ruled out or in the rare case it is diagnosed, appropriate treatment can be given to the patient.

In the study “Pembrolizumab-associated sarcoidosis,” researchers described the first case of sarcoidosis after a patient was treated with after Keytruda (pembrolizumab) to inhibit the programmed cell death-1 (PD-1) receptor. The study was published in the JAAD Case Reports journal. Keytruda is a humanized antibody that targets the PD-1…

When skin sarcoidosis is associated with pre-existing scars, it is called scar sarcoidosis. In a recent study, researchers at the Chungnam National University School of Medicine in Korea reported the case of a patient who developed scar sarcoidosis following pulsed dye laser treatment for a pre-existing scar. The study, “…

Sarcoidosis patients appear to have unusual energy production and transmethylation of proteins, as well as an abnormal gut microbiota, according to researchers at Wayne State University School of Medicine and colleagues, who compared the metabolites found in sarcoidosis patients with those of healthy people. The study, “Metabolomics connects aberrant bioenergetic, transmethylation,…

Cancer immunotherapy with Opdivo (nivolumab) and Yervoy (ipilimumab) may or may not trigger sarcoidosis in rare cases, a report from Yale University School of Medicine shows. The study, “Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy,” published in the Journal of the American Academy of…